LIGNOCAINE Side Effects

6435775-3 | Delirium, Paralysis
on Nov 02, 2009 Female patient from NEW ZEALAND , 49 years of age, was treated with Lignocaine (View Usage). Patient experienced the following unwanted or unexpected effects: delirium, paralysis (What is paralysis?). Lignocaine dosage: Single Dose. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6427894-2 | Anaphylactic Reaction
Patient was taking Lignocaine (View Usage). Patient had the following side effects: anaphylactic reaction on Nov 02, 2009 from NEW ZEALAND Additional patient health information: Male patient , 56 years of age, . Lignocaine dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ).

6299283-5 | Dyspnoea, Heart Rate Increased, Loss Of Consciousness
Adverse event was reported on Aug 03, 2009 by a Female patient taking Lignocaine (View Usage) (Dosage: ) . Location: AUSTRALIA , 80 years of age, After Lignocaine was administered, patient had the following side effects: dyspnoea, heart rate increased, loss of consciousness. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), HYALASE (View Hyalase Review and Hyalase Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

6294342-5 | Anxiety, Chills, Disorientation, Gait Disturbance, Hearing Impaired, Injection Site Pain, Insomnia, Speech Disorder
on Feb 05, 2009 Female patient from AUSTRALIA , 55 years of age, was diagnosed with intervertebral disc protrusion and was treated with Lignocaine (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), chills, disorientation, gait disturbance, hearing impaired, injection site pain, insomnia, speech disorder. Lignocaine dosage: . During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), CELESTONE (View Celestone Review and Celestone Label ).


5714933-7 | Bradycardia, Hypotension, Syncope Vasovagal
on Apr 18, 2008 Male patient from UNITED KINGDOM , 39 years of age, was diagnosed with local anaesthesia, depression (What is depression?), anxiety (What is anxiety?) and was treated with Lignocaine (View Usage). Patient had the following side effects: bradycardia, hypotension, syncope vasovagal. Lignocaine dosage: . During the same period patient was treated with CHIROCAINE (107048w01) (View Chirocaine Review and Chirocaine Label ), CYMBALTA (30 Mg) (View Cymbalta Review and Cymbalta Label ), PROPRANOLOL (40 Mg) (View Propranolol Review and Propranolol Label ).

5557895-8 | Dyspnoea, Rash, Wheezing
Patient was taking Lignocaine (View Usage). After Lignocaine was administered, patient had the following side effects: dyspnoea, rash (What is rash?), wheezing on Dec 11, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 52 years of age, was diagnosed with bronchoscopy and. Lignocaine dosage: .

5523622-3 | Emotional Distress, Hypoaesthesia Oral, Paraesthesia Oral, Tearfulness
Adverse event was reported on Nov 09, 2007 by a Female patient taking Lignocaine (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: UNITED KINGDOM , 45 years of age, Patient experienced the following unwanted or unexpected effects: emotional distress, hypoaesthesia oral, paraesthesia oral, tearfulness.

5521125-3 | Angioedema, Convulsion, Renal Failure Acute, Swollen Tongue
on Nov 13, 2007 Male patient from UNITED KINGDOM , 70 years of age, was treated with Lignocaine (View Usage). Patient had the following side effects: angioedema, convulsion, renal failure acute, swollen tongue. Lignocaine dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5451345-8 | Completed Suicide, Overdose
on Sep 10, 2007 Female patient from UNITED KINGDOM , 31 years of age, was treated with Lignocaine (View Usage). After Lignocaine was administered, patient had the following side effects: completed suicide, overdose. Lignocaine dosage: .

5447774-9 | Intentional Overdose
Patient was taking Lignocaine (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose on Sep 05, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 58 years of age, . Lignocaine dosage: .

5447767-1 | Intentional Overdose
Adverse event was reported on Sep 05, 2007 by a Female patient taking Lignocaine (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 20 years of age, Patient had the following side effects: intentional overdose. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), MEFENAMIC ACID (View Mefenamic Acid Review and Mefenamic Acid Label ).

5443079-0 | Intentional Overdose
on Aug 28, 2007 Male patient from ITALY , 58 years of age, was treated with Lignocaine (View Usage). After Lignocaine was administered, patient had the following side effects: intentional overdose. Lignocaine dosage: .

5419782-5 | Metabolic Acidosis, Overdose, Tachycardia
on Aug 14, 2007 Male patient from UNITED KINGDOM , 19 years of age, was treated with Lignocaine (View Usage). Patient experienced the following unwanted or unexpected effects: metabolic acidosis, overdose, tachycardia. Lignocaine dosage: . During the same period patient was treated with IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), PHENYLPROPANOLAMINE (View Phenylpropanolamine Review and Phenylpropanolamine Label ), CHLORPHENIRAMINE TAB (View Chlorpheniramine Tab Review and Chlorpheniramine Tab Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

5406290-0 | Metabolic Acidosis, Overdose, Tachycardia
Patient was taking Lignocaine (View Usage). Patient had the following side effects: metabolic acidosis, overdose, tachycardia on Aug 01, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 19 years of age, . Lignocaine dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), PHENYLPROPANOLAMINE (View Phenylpropanolamine Review and Phenylpropanolamine Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

5347809-8 | Diplegia, Sensory Loss
Adverse event was reported on May 23, 2007 by a Female patient taking Lignocaine (View Usage) (Dosage: ) was diagnosed with skin laceration, tooth disorder (What is tooth disorder?) and. Location: UNITED KINGDOM , 36 years of age, After Lignocaine was administered, patient had the following side effects: diplegia, sensory loss.

5149730-7 | Chest Discomfort, Feeling Hot, Pruritus
on Nov 01, 2006 Female patient from UNITED KINGDOM , 30 years of age, was treated with Lignocaine (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, feeling hot, pruritus. Lignocaine dosage: . During the same period patient was treated with BENZATHINE PENICILLIN G (2.4 Million International Units) (View Benzathine Penicillin G Review and Benzathine Penicillin G Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ).

5125831-4 | Bronchospasm, Circulatory Collapse
on Oct 09, 2006 Female patient from UNITED KINGDOM , 39 years of age, weighting 154.3 lb, was diagnosed with anaesthesia, thyroidectomy and was treated with Lignocaine (View Usage). Patient had the following side effects: bronchospasm, circulatory collapse. Lignocaine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ROCURONIUM (View Rocuronium Review and Rocuronium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), INHALER (View Inhaler Review and Inhaler Label ), ORAL CONTRACEPTIVE (View Oral Contraceptive Review and Oral Contraceptive Label ). Patient was hospitalized.

5086788-8 | Colon Gangrene, Grand Mal Convulsion, Intestinal Gangrene, Intestinal Infarction, Myocardial Infarction
Patient was taking Lignocaine (View Usage). After Lignocaine was administered, patient had the following side effects: colon gangrene, grand mal convulsion, intestinal gangrene, intestinal infarction, myocardial infarction on Aug 01, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 72 years of age, was diagnosed with sedation and. Lignocaine dosage: 2% In Error Instead Of 1%.

5072340-7 | Colon Gangrene, Grand Mal Convulsion, Myocardial Infarction
Adverse event was reported on Aug 01, 2006 by a Male patient taking Lignocaine (View Usage) (Dosage: 2% In Error Instead Of 1%) was diagnosed with sedation and. Location: UNITED KINGDOM , 72 years of age, Patient experienced the following unwanted or unexpected effects: colon gangrene, grand mal convulsion, myocardial infarction.

5033139-0 | Diplopia, Muscle Atrophy, Muscle Fibrosis, Muscle Injury, Muscle Tightness, Strabismus, Vision Blurred
on Jun 12, 2006 Male patient from LEBANON , 72 years of age, was diagnosed with local anaesthesia and was treated with Lignocaine (View Usage). Patient had the following side effects: diplopia, muscle atrophy, muscle fibrosis, muscle injury, muscle tightness, strabismus, vision blurred. Lignocaine dosage: . During the same period patient was treated with BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), HYALURONIDASE (View Hyaluronidase Review and Hyaluronidase Label ).

4922054-6 | Conjunctival Oedema, Exophthalmos, Eye Inflammation, Eye Movement Disorder, Eye Oedema, Iatrogenic Injury, Muscle Swelling, Ocular Discomfort, Optic Nerve Disorder
on Feb 13, 2006 Female patient from UNITED KINGDOM , 74 years of age, was diagnosed with local anaesthesia, prophylaxis and was treated with Lignocaine (View Usage). After Lignocaine was administered, patient had the following side effects: conjunctival oedema, exophthalmos, eye inflammation, eye movement disorder, eye oedema, iatrogenic injury, muscle swelling, ocular discomfort, optic nerve disorder. Lignocaine dosage: Injected Into Sub-tenon's Space.. During the same period patient was treated with BUPIVACAINE (Injected Into Sub-tenon's Space.) (View Bupivacaine Review and Bupivacaine Label ), HYALURONIDASE (Injected Into Sub-tenon's Space.) (View Hyaluronidase Review and Hyaluronidase Label ), PROXYMETACAINE (View Proxymetacaine Review and Proxymetacaine Label ), POVIDONE IODINE (Instilled Into Conjunctival Sac.) (View Povidone Iodine Review and Povidone Iodine Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

4921580-3 | Conjunctival Oedema, Exophthalmos, Eye Inflammation, Eye Pain, Intraocular Pressure Increased, Intraocular Pressure Test, Soft Tissue Injury
Patient was taking Lignocaine (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival oedema, exophthalmos, eye inflammation, eye pain, intraocular pressure increased, intraocular pressure test, soft tissue injury on Feb 13, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 74 years of age, was diagnosed with local anaesthesia, prophylaxis and. Lignocaine dosage: Injected Into Sub-tenon's Space. During the same period patient was treated with BUPIVACAINE (Injected Into Sub-tenon's Space) (View Bupivacaine Review and Bupivacaine Label ), HYALURONIDASE (Injected Into Sub-tenon's Space) (View Hyaluronidase Review and Hyaluronidase Label ), PROXYMETACAINE (View Proxymetacaine Review and Proxymetacaine Label ), POVIDONE IODINE (Instilled Into Conjunctival Sac) (View Povidone Iodine Review and Povidone Iodine Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ).

4891232-7 | Exophthalmos, Eye Movement Disorder, Eyelid Oedema
Adverse event was reported on Jan 16, 2006 by a Female patient taking Lignocaine (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: UNITED KINGDOM , 72 years of age, Patient had the following side effects: exophthalmos, eye movement disorder, eyelid oedema. During the same period patient was treated with HYALURONIDASE (View Hyaluronidase Review and Hyaluronidase Label ). Patient was hospitalized.

4752104-1 | Hypersensitivity
on Jul 26, 2005 Female patient from AUSTRALIA , weighting 134.5 lb, was diagnosed with migraine (What is migraine?) and was treated with Lignocaine (View Usage). After Lignocaine was administered, patient had the following side effects: hypersensitivity. Lignocaine dosage: Initial Loading Dose Only. Patient was hospitalized.

4737031-8 | Dizziness, Wheezing
on Jul 26, 2005 Female patient from AUSTRALIA , weighting 134.5 lb, was diagnosed with migraine (What is migraine?) and was treated with Lignocaine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), wheezing. Lignocaine dosage: Initial Loading Dose Only. Patient was hospitalized.

4735475-1 | Wheezing
Patient was taking Lignocaine (View Usage). Patient had the following side effects: wheezing on Jul 26, 2005 from AUSTRALIA Additional patient health information: Female patient , weighting 123.5 lb, . Lignocaine dosage: 1:10 Dilution Of 1%. During the same period patient was treated with EMLA (View Emla Review and Emla Label ), STINGOSE (View Stingose Review and Stingose Label ). Patient was hospitalized.

4676696-6 | Adductor Vocal Cord Weakness, Laryngospasm
Adverse event was reported on May 18, 2005 by a Female patient taking Lignocaine (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: , 54 years of age, After Lignocaine was administered, patient had the following side effects: adductor vocal cord weakness, laryngospasm. During the same period patient was treated with MIDAZOLAM (View Midazolam Review and Midazolam Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ), ULTANE (View Ultane Review and Ultane Label ).

4664346-4 | Corneal Epithelium Disorder
on May 03, 2005 Female patient from , 85 years of age, was treated with Lignocaine (View Usage). Patient experienced the following unwanted or unexpected effects: corneal epithelium disorder. Lignocaine dosage: 40mg/2ml, 2% Strength. During the same period patient was treated with AMETHOCAINE (1 + 0.5%) (View Amethocaine Review and Amethocaine Label ), HEALONID (View Healonid Review and Healonid Label ), GENTAMICIN (80mg/2ml) (View Gentamicin Review and Gentamicin Label ), CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), BENOXINATE HYDROCHLORIDE (View Benoxinate Hydrochloride Review and Benoxinate Hydrochloride Label ), ZINACEF (View Zinacef Review and Zinacef Label ).

4596823-9 | Grand Mal Convulsion, Injury, Laceration, Paraesthesia Oral, Procedural Complication
on Feb 14, 2005 Male patient from , 40 years of age, was treated with Lignocaine (View Usage). Patient had the following side effects: grand mal convulsion, injury, laceration, paraesthesia oral, procedural complication. Lignocaine dosage: 40 Ml Once Ur. During the same period patient was treated with BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ).

4592657-X | Swelling Face, Type Iv Hypersensitivity Reaction
Patient was taking Lignocaine (View Usage). After Lignocaine was administered, patient had the following side effects: swelling face, type iv hypersensitivity reaction on Feb 04, 2005 from Additional patient health information: Male patient , 39 years of age, was diagnosed with local anaesthesia and. Lignocaine dosage: . Patient was hospitalized.

4592586-1 | Dyspnoea, Eye Swelling, Hyperhidrosis, Nausea, Rash
Adverse event was reported on Feb 04, 2005 by a Female patient taking Lignocaine (View Usage) (Dosage: 10 Ml) . Location: , 56 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, eye swelling, hyperhidrosis, nausea (What is nausea?), rash (What is rash?). During the same period patient was treated with PROTAMINE SULFATE (30 Mg Iv) (View Protamine Sulfate Review and Protamine Sulfate Label ), PROGRAF (View Prograf Review and Prograf Label ), CCELLCEPT (View Ccellcept Review and Ccellcept Label ), NORVASC (View Norvasc Review and Norvasc Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), VISAPAQUE (270mg Iv) (View Visapaque Review and Visapaque Label ).

4592585-X | Chills, Dyspnoea, Tremor
on Feb 04, 2005 Male patient from , 63 years of age, was treated with Lignocaine (View Usage). Patient had the following side effects: chills, dyspnoea, tremor. Lignocaine dosage: 10 Ml Daily Iv. During the same period patient was treated with ISOVUE (65 Ml Daily Po) (View Isovue Review and Isovue Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

4591159-4 | Anaphylactic Reaction, Bronchospasm, Hypotension
on Feb 04, 2005 Male patient from , 69 years of age, was diagnosed with anaesthesia and was treated with Lignocaine (View Usage). After Lignocaine was administered, patient had the following side effects: anaphylactic reaction, bronchospasm, hypotension. Lignocaine dosage: . During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ). Patient was hospitalized.

4590033-7 | Dizziness, Dysgeusia, Tinnitus
Patient was taking Lignocaine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dysgeusia, tinnitus (What is tinnitus?) on Feb 04, 2005 from Additional patient health information: Male patient , 14 years of age, weighting 121.3 lb, . Lignocaine dosage: 24 Ml Daily Iv. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.